[ CrossRef] [ PubMed ] Damiano OM, Stevens AJ, Kenwright DN, Seddon AR
Timothy Garvey served as principal investigator for the landmark REDEFINE 1 trial published in The New England Journal of Medicine in 2025, which established the GLP1-cagrilintide combination as producing the highest pharmaceutical weight loss observed to date
Treatment for Sulfa Allergy The primary treatment for a sulfa allergy is to stop taking the sulfa drug that has triggered the reaction
While human data is still emerging, results have been consistently promising in both acute and chronic injury models
Manual annotation based on functional keywords (e.g., hydrolase activity (KW-0378), exopeptidase, endopeptidase) 30 , identified 73 of these enriched proteins as SHs, representing 24.5% of the FP-labelled proteome (Fig